Iman Osman

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Advanced Cancer

Respiratory Syndrome Coronavirus

Top Venues

Journal of translational medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer reports (Hoboken, N.J.)

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Kelsey R Monson, Robert Ferguson, Joanna E Handzlik, Jiahan Xiong, Sasha Dagayev, Leah J Morales, Vylyny Chat, Anabelle Bunis, Chaitra Sreenivasaiah, Sonia Dolfi, Daniel J Tenney, Yongzhao Shao, Iman Osman, Jeffrey S Weber, Tomas Kirchhoff
Tyrosine-protein kinase SYK-related gene signature in baseline immune cells associated with adjuvant immunotherapy-induced immune-related adverse events in melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kelsey R Monson, Robert Ferguson, Joanna E Handzlik, Jiahan Xiong, Sasha Dagayev, Leah J Morales, Vylyny Chat, Anabelle Bunis, Chaitra Sreenivasaiah, Sonia Dolfi, Daniel J Tenney, Yongzhao Shao, Iman Osman, Jeffrey S Weber, Tomas Kirchhoff
Tyrosine-protein kinase SYK-related gene signature in baseline immune cells associated with adjuvant immunotherapy-induced immune-related adverse events in melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rana S Moubarak, Ana de Pablos-Aragoneses, Vanessa Ortiz-Barahona, Yixiao Gong, Michael Gowen, Igor Dolgalev, Sorin A A Shadaloey, Diana Argibay, Alcida Karz, Richard Von Itter, Eleazar Carmelo Vega-Sáenz de Miera, Elena Sokolova, Farbod Darvishian, Aristotelis Tsirigos, Iman Osman
The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis. Science advances 8 (7) (2022)
Paul Johannet, Morgan Simons, Yingzhi Qian, Nadine Azmy, Janice M Mehnert, Jeffrey S Weber, Judy Zhong, Iman Osman
Risk and tropism of central nervous system (CNS) metastases in patients with stage II and III cutaneous melanoma. Cancer 128 (20) (2022)
Paul Johannet, Wenke Liu, David Fenyo, Megan Wind-Rotolo, Michelle Krogsgaard, Janice M Mehnert, Jeffrey S Weber, Judy Zhong, Iman Osman
Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Paul Johannet, Amelia Sawyers, Nicholas Gulati, Douglas Donnelly, Samuel Kozloff, Yingzhi Qian, Alfredo Floristan, Eva Hernando, Judy Zhong, Iman Osman
Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients. Journal of translational medicine 19 (1) (2021)
Amelia Sawyers, Margaret Chou, Paul Johannet, Nicholas Gulati, Yingzhi Qian, Judy Zhong, Iman Osman
Clinical outcomes in cancer patients with COVID-19. Cancer reports (Hoboken, N.J.) (2021)
Nicholas Gulati, Arda B Celen, Paul Johannet, Janice M Mehnert, Jeffrey Weber, Michelle Krogsgaard, Iman Osman, Judy Zhong
Preexisting immune-mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors. Cancer medicine 10 (21) (2021)
Iman Osman, Paolo Cotzia, Una Moran, Douglas Donnelly, Carolina Arguelles-Grande, Sandra Mendoza, Andre Moreira
Correction to: The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic. Journal of translational medicine 19 (1) (2021)
Iman Osman, Paolo Cotzia, Una Moran, Douglas Donnelly, Carolina Arguelles-Grande, Sandra Mendoza, Andre Moreira
The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic. Journal of translational medicine 18 (1) (2020)
Michael F Gowen, Keith M Giles, Danny Simpson, Jeremy Tchack, Hua Zhou, Una Moran, Zarmeena Dawood, Anna C Pavlick, Shaohui Hu, Melissa A Wilson, Hua Zhong, Michelle Krogsgaard, Tomas Kirchhoff, Iman Osman
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors. Journal of translational medicine 16 (1) (2018)